America has always been a leader in developing cutting-edge medical treatments and technologies, breakthroughs that have saved countless lives; but due to outdated and burdensome Federal healthcare policies, medical innovation in our country is failing to keep pace with the 21st century challenges facing doctors and families. Today, Americans nationwide are being forced to wait for the lifesaving treatments they need while important advancements are held up by unnecessary red tape. Chairman Upton's 21st Century Cures Act provides an opportunity to put America back at the forefront of medical innovation and the delivery of cutting-edge care. This legislation will empower America's researchers and doctors with the tools needed to solve the biggest healthcare challenges of our time. It includes many bipartisan solutions that will increase healthcare choice, access, and affordability for the American people. Thanks to Chairman Upton's leadership and the hard work of many Members of Congress from multiple committees, the 21st Century Cures Act brings together a variety of solutions that will help Americans throughout the country. Ten of these patient-focused measures are from the Ways and Means Committee. All 10 are bipartisan. More than 20 of our members crafted and introduced these bills. Many more helped move them forward.…
Kevin Brady: “America has always been a leader in developing cutting-edge medical treatments and technologies, breakthroughs that have…”
Share
More from Kevin Brady
I am proud to yield 2 minutes to the gentleman from South Carolina (Mr. Rice), the Republican leader of the Oversight Subcommittee.
On this day in 1788, the United States Constitution was ratified making that remarkable document the law of this land, and it began with those immortal words: ``We the People.'' So 234 years to the day after that call to create a more…
I include in the Record the following Joint Committee on Taxation analysis that shows that American manufacturers are hardest hit by the Democrats' made in America tax--$200 billion-- and they will pay over half of that tax. Congress of…
On behalf of seniors who rely on generic drugs, I include in the Record the following letter from generic and biosimilar manufacturers, which explains the price controls in this Democrat bill will reduce competition from lower-cost generic…





